Evidence map›Paper›PMID 12761605›Full record

Trial reportEuropean journal of clinical pharmacology2003

Paracetamol and metabolite pharmacokinetics in infants.

Caroline D van der Marel, Brian J Anderson, Richard A van Lingen, Nicholas H G Holford, Marien A L Pluim, Frank G A Jansman, John N van den Anker, Dick Tibboel

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in European journal of clinical pharmacology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 98 citations in OpenAlex.

  1. Successful Use of [Clinical pharmacokinetics · 2017
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Clinical pharmacology of paracetamol in neonates: a review.Current therapeutic research, clinical and experimental · 2015
    Review
  13. Article
  14. Article
  15. Paracetamol: a focus for the general pediatrician.European journal of pediatrics · 2014
    Review
  16. Review
  17. Prenatal and perinatal analgesic exposure and autism: an ecological link.Environmental health : a global access science source · 2013
    Article
  18. Safety and population pharmacokinetic analysis of intravenous acetaminophen in neonates, infants, children, and adolescents with pain or Fever.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2011
    Article
  19. Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease.Journal of pediatric gastroenterology and nutrition · 2011
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Caroline D van der MarelDepartment of Paediatric Surgery, Erasmus MC-Sophia, Dr. Molenwaterplein 60, 3016 GJ Rotterdam, The Netherlands.
Brian J Anderson
Richard A van Lingen
Nicholas H G Holford
Marien A L Pluim
Frank G A Jansman
John N van den Anker
Dick Tibboel
Erasmus MC - Sophia Children’s Hospital · NLIsala · NLGeorge Washington University · USMaastricht University Medical Centre · NLUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData concerning metabolism of paracetamol in infants are scant. Previous studies have examined urinary metabolite recovery rates after a single dose of paracetamol in either neonates (<6 weeks) or children (3-9 years). There are no studies investigating infants.

methodsInfants ( n=47) undergoing major craniofacial surgery were given paracetamol 19-45 mg/kg 6-, 8-, or 12-hourly as either elixir or suppository formulation for postoperative analgesia, after a loading dose of 33-59 mg/kg rectally during the operation. Serum was assayed for paracetamol concentration in 40 of these infants at 5, 8, 11, 14, 17 and 20 h postoperatively. Urine samples were collected every 3 h for 24 h in 15 of these infants. The clearances of paracetamol to glucuronide and sulphate metabolites as well as the urinary clearance of unmetabolised paracetamol were estimated using non-linear, mixed-effects models.

resultsMean (+/-SD) age and weight of the patients were 11.8+/-2.5 months and 9.1+/-1.9 kg. Clearances of paracetamol to paracetamol-glucuronide (%CV) and to paracetamol-sulphate were 6.6 (11.5) l/h and 7.5 (11.5) l/h respectively, standardised to a 70-kg person using allometric "1/4 power" models. Glucuronide formation clearance, but not sulphate formation, was related to age and increased with age from a predicted value in a neonate of 2.73 l/h/70 kg to a mature value of 6.6 l/h/70 kg with a maturation half-life of 8.09 months. Urine clearance of paracetamol-glucuronide, paracetamol-sulphate and unchanged paracetamol (%CV) were, respectively, 2.65, 3.03 and 0.55 (28) l/h/70 kg. The urine clearance of unchanged paracetamol and metabolites was related to urine volume flow rate. Clearance attributable to pathways other than these measured in urine was not identifiable. The glucuronide/sulphate formation clearance ratio was 0.69 at 12 months of age. Sulphate metabolism contributed 50% towards paracetamol clearance.

conclusionGlucuronide formation clearance increases with age in the infant age range but sulphate formation does not. Renal clearance of paracetamol and its metabolites increases with urine flow rate. This and other studies show that paracetamol metabolism to glucuronide appears to be similar in infants and children, but in adults is increased in comparison with children. Oxidative pathways were undetectable in this infant study and may explain, in part, the reduced incidence of hepatotoxicity in infants.

Indexed as

AcetaminophenAnalgesics, Non-NarcoticFemaleHumansInfantMaleMetabolic Clearance RatePostoperative PainAcetaminophenacetaminophen glucuronideacetaminophen sulfate esterAnalgesics, Non-Narcotic

Identifiers

PMID12761605
OpenAlexW1999869154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.